BORMANN-KENNEDY BARBARA-JEAN ANNE 4
4 · Xeris Biopharma Holdings, Inc. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2023-06-07+42,500→ 57,500 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.